Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy

Urology

Volumn 55, Issue 2, 2000, Pages 236-240

  Hahn, R G ^a   Farahmand, B Y ^b   Hallin, A ^b   Hannar, N ^b   Persson, P G ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

EID: 0033985490     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00417-3     Document Type: Article

References (26)

1. Uchida T., Ohori M., Soh S., et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology. 53:1999;98-105.
2. Roos N.P., Wennberg J.E., Malenka D.J., et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 320:1989;1120-1124.
3. Malenka D.J., Roos N., Fisher E.S., et al. Further study of the increased mortality following transurethral prostatectomy a chart-based analysis . J Urol. 144:1990;224-228.
4. Sidney S., Quesenberry C.P., Sadler M.C., et al. Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program. Med Care. 30:1992;117-125.
5. Hargreave T.B., Heynes C.F., Kendrick S.W., et al. Mortality after transurethral and open prostatectomy in Scotland. Br J Urol. 77:1996;547-553.
6. Hooten M.E., Finstuen K., Thompson I.M. Multivariate case-control study of survival following transurethral resection of the prostate. Urology. 39:1992;111-116.
7. Andersen T.F., Brönnum-Hansen H., Sejr T., et al. Elevated mortality following transurethral resection of the prostate for benign hypertrophy! But why? Med Care. 28:1990;870-881.
8. Concato J., Horwitz R.I., Feinstein A.R., et al. Problems of comorbidity in mortality after prostatectomy. JAMA. 267:1992;1077-1082.
9. Taylor Z., Krakauer H. Mortality and reoperation following prostatectomy outcomes in a Medicare population . Urology. 38:1991;27-30.
10. Seagroatt V. Mortality after prostatectomy selection and surgical approach . Lancet. 346:1995;1521-1524.
11. Coppinger S.W.V., Hudd C. Risk factor for myocardial infarction in transurethral resection of the prostate. Lancet. 2:1989;859.
12. Evans J.W.H., Singer M., Chapple C.R., et al. Haemodynamic evidence for cardiac stress during transurethral prostatectomy. BMJ. 304:1992;666-671.
13. Hahn R.G., Essén P. ECG and cardiac enzymes after glycine absorption in transurethral prostatic resection. Acta Anaesthesiol Scand. 38:1994;550-556.
14. Hahn R.G., Nilsson A., Farahmand B., et al. Operative factors and the long-term risk of acute myocardial infarction after transurethral resection of the prostate. Epidemiology. 6:1996;93-95.
15. Carter S.S., Patel A., Royer P., et al. Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction. J Endourol. 5:1991;137-144.
16. Hahn R.G., Ekengren J. Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol. 149:1993;502-506.
17. Hahn R.G. Ethanol monitoring of irrigating fluid absorption. Eur J Anaesth. 13:1996;102-115.
18. Hallin A., Berlin T. Transurethral microwave thermotherapy of benign prostatic hyperplasia do any pretreatment conditions predict the result? Eur Urol. 30:1996;429-436.
19. Ahlbom A. Acute myocardial infarction in Stockholm - a medical information system as an epidemiological tool. Int J Epidemiol. 7:1978;271-276.
20. Hammar N., Nerbrand C., Ahlmark G., et al. Identification of cases of myocardial infarction hospital discharge data and mortality data compared to myocardial infarction registers . Int J Epidemiol. 20:1991;114-120.
21. Zhang W., Andersson B., Hahn R.G. Effect of irrigating fluids and prostatic tissue extracts on isolated cardiomyocytes. Urology. 46:1995;821-824.
22. Hahn R.G., Nennesmo I., Rajs J., et al. Morphological and x-ray microanalytical changes in mammalian tissue after overhydration with irrigating fluids. Eur Urol. 29:1996;355-361.
23. Hahn R.G., Zhang W., Rajs J. Morphology of the heart after overhydration with glycine solution in the mouse. APMIS. 104:1996;915-920.
24. Hammarsten J., Högstedt B., Holthuis N., et al. Components of the metabolic syndrome - risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostate Dis. 1:1998;157-162.
25. Hanglund B.J., Isacsson S.O., Rydén L., et al. Health profile of Skaraborg county 1977. A Swedish rural cross-sectional study. Scand J Prim Health Care. 1:1993;102-113.
26. Agnér E. Natural history of angina pectoris, possible previous myocardial infarction and intermittent claudication during the eighth decade. A longitudinal epidemiologic study. Acta Med Scand. 210:1981;271-276.